| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 165.88B | 150.22B | 115.50B | 106.38B | 99.25B | 82.54B |
| Gross Profit | 46.47B | 42.73B | 33.38B | 28.63B | 27.50B | 25.23B |
| EBITDA | 11.43B | 9.82B | 8.20B | 5.21B | 5.74B | 5.07B |
| Net Income | 2.82B | 2.76B | 8.71B | 6.19B | 2.83B | 607.00M |
Balance Sheet | ||||||
| Total Assets | 233.22B | 236.76B | 187.96B | 171.37B | 168.59B | 164.20B |
| Cash, Cash Equivalents and Short-Term Investments | 40.02B | 41.73B | 52.56B | 46.49B | 44.53B | 46.26B |
| Total Debt | 47.87B | 51.17B | 14.93B | 15.50B | 19.78B | 20.62B |
| Total Liabilities | 108.82B | 109.64B | 60.82B | 59.61B | 58.94B | 60.07B |
| Stockholders Equity | 117.08B | 119.62B | 120.57B | 105.78B | 104.09B | 98.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.22B | 2.83B | 2.04B | 1.37B | 4.83B |
| Operating Cash Flow | 0.00 | 2.35B | 5.94B | 5.49B | 4.09B | 8.09B |
| Investing Cash Flow | 0.00 | -30.33B | -726.00M | -1.62B | -1.19B | -1.80B |
| Financing Cash Flow | 0.00 | 15.27B | -3.04B | -7.09B | -2.75B | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥85.60B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
76 Outperform | ¥57.26B | 10.64 | ― | 2.79% | 2.85% | 3.17% | |
75 Outperform | ¥64.47B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥49.76B | 23.59 | 2.46% | 4.09% | 30.99% | -65.52% | |
74 Outperform | ¥57.34B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
70 Outperform | ¥87.94B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |